APYX
Price
$1.16
Change
-$0.07 (-5.69%)
Updated
Apr 3 closing price
Capitalization
47.46M
34 days until earnings call
QDEL
Price
$32.49
Change
-$2.14 (-6.18%)
Updated
Apr 3 closing price
Capitalization
3.14B
26 days until earnings call
Ad is loading...

APYX vs QDEL

Header iconAPYX vs QDEL Comparison
Open Charts APYX vs QDELBanner chart's image
Apyx Medical
Price$1.16
Change-$0.07 (-5.69%)
Volume$29.19K
Capitalization47.46M
QuidelOrtho
Price$32.49
Change-$2.14 (-6.18%)
Volume$1.52M
Capitalization3.14B
APYX vs QDEL Comparison Chart
Loading...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APYX vs. QDEL commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a Hold and QDEL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (APYX: $1.16 vs. QDEL: $32.49)
Brand notoriety: APYX and QDEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: APYX: 80% vs. QDEL: 178%
Market capitalization -- APYX: $47.46M vs. QDEL: $3.14B
APYX [@Medical Specialties] is valued at $47.46M. QDEL’s [@Medical Specialties] market capitalization is $3.14B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APYX’s FA Score shows that 0 FA rating(s) are green whileQDEL’s FA Score has 1 green FA rating(s).

  • APYX’s FA Score: 0 green, 5 red.
  • QDEL’s FA Score: 1 green, 4 red.
According to our system of comparison, QDEL is a better buy in the long-term than APYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APYX’s TA Score shows that 4 TA indicator(s) are bullish while QDEL’s TA Score has 4 bullish TA indicator(s).

  • APYX’s TA Score: 4 bullish, 6 bearish.
  • QDEL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, QDEL is a better buy in the short-term than APYX.

Price Growth

APYX (@Medical Specialties) experienced а -11.45% price change this week, while QDEL (@Medical Specialties) price change was -9.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.68%. For the same industry, the average monthly price growth was +1.30%, and the average quarterly price growth was +1.15%.

Reported Earning Dates

APYX is expected to report earnings on May 08, 2025.

QDEL is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (-4.68% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QDEL($3.14B) has a higher market cap than APYX($47.5M). APYX (-26.582) and QDEL (-27.071) have similar YTD gains . QDEL has higher annual earnings (EBITDA): 607M vs. APYX (-18.11M). QDEL has more cash in the bank: 167M vs. APYX (43.7M). APYX has less debt than QDEL: APYX (38.5M) vs QDEL (2.61B). QDEL has higher revenues than APYX: QDEL (3B) vs APYX (52.3M).
APYXQDELAPYX / QDEL
Capitalization47.5M3.14B2%
EBITDA-18.11M607M-3%
Gain YTD-26.582-27.07198%
P/E RatioN/A9.76-
Revenue52.3M3B2%
Total Cash43.7M167M26%
Total Debt38.5M2.61B1%
FUNDAMENTALS RATINGS
APYX vs QDEL: Fundamental Ratings
APYX
QDEL
OUTLOOK RATING
1..100
737
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
7782
P/E GROWTH RATING
1..100
10012
SEASONALITY SCORE
1..100
1675

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APYX's Valuation (55) in the Medical Specialties industry is in the same range as QDEL (57). This means that APYX’s stock grew similarly to QDEL’s over the last 12 months.

APYX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as QDEL (100). This means that APYX’s stock grew similarly to QDEL’s over the last 12 months.

QDEL's SMR Rating (97) in the Medical Specialties industry is in the same range as APYX (99). This means that QDEL’s stock grew similarly to APYX’s over the last 12 months.

APYX's Price Growth Rating (77) in the Medical Specialties industry is in the same range as QDEL (82). This means that APYX’s stock grew similarly to QDEL’s over the last 12 months.

QDEL's P/E Growth Rating (12) in the Medical Specialties industry is significantly better than the same rating for APYX (100). This means that QDEL’s stock grew significantly faster than APYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APYXQDEL
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 12 days ago
70%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 10 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
69%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTY30.34-0.22
-0.72%
Getty Realty Corp
GD269.62-6.42
-2.33%
General Dynamics Corp
OBDC14.40-0.38
-2.57%
Blue Owl Capital Corp
MSB25.73-1.10
-4.10%
Mesabi Trust
RANI1.30-0.09
-6.47%
Rani Therapeutics Holdings

APYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, APYX has been loosely correlated with CORBF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APYX jumps, then CORBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APYX
1D Price
Change %
APYX100%
-5.69%
CORBF - APYX
36%
Loosely correlated
N/A
MKEAF - APYX
33%
Loosely correlated
N/A
AVGR - APYX
27%
Poorly correlated
N/A
QDEL - APYX
26%
Poorly correlated
-6.18%
NVCR - APYX
26%
Poorly correlated
-5.35%
More

QDEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, QDEL has been loosely correlated with BIO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if QDEL jumps, then BIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QDEL
1D Price
Change %
QDEL100%
-6.18%
BIO - QDEL
50%
Loosely correlated
-4.39%
DHR - QDEL
44%
Loosely correlated
-3.54%
CRL - QDEL
42%
Loosely correlated
-5.56%
IQV - QDEL
42%
Loosely correlated
-3.83%
SHC - QDEL
41%
Loosely correlated
-6.70%
More